Every Form 4 that Community Health Systems, Inc. (CYH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CYH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CYH filings page.
COMMUNITY HEALTH SYSTEMS INC (CYH) director William Norris Jennings reported selling 40,000 shares of Common Stock on August 25, 2026 in open market or private transactions at a weighted average price of $2.959 per share, with individual trade prices ranging from $2.945 to $2.975.
After this sale, Jennings directly holds 38,468 shares of Common Stock and restricted stock units representing 275,271 underlying shares. These restricted stock units vest in one-third increments on the first, second and third anniversaries of the grant date and, pursuant to prior deferral elections, will be settled in an equal number of CYH common shares upon his cessation as a director or on previously specified dates.
COMMUNITY HEALTH SYSTEMS INC director K Ranga Krishnan increased his equity stake through compensation-related share conversions. On June 30, he exercised stock units to acquire 13,930 shares of common stock, a non-cash derivative exercise reported at a $0.00 exercise price.
Following the transactions, he directly holds 170,023 shares of common stock. He also retains 55,722.712 Stock Units (SU) and restricted stock units tied to 228,321 underlying common shares, which will be settled in stock under the company’s Directors' Fees Deferral Plan or upon his cessation as a director, consistent with prior deferral elections.
COMMUNITY HEALTH SYSTEMS INC reported that EVP-Clinical Operations & CMO David V. Rice received several equity awards as compensation. He was granted 30,000 shares of common stock that vest in one-third increments on the first, second and third anniversaries of the June 1, 2026 grant date, giving him 30,000 common shares directly following this grant.
He was also granted 30,000 stock options with a $2.75 per share exercise price, expiring on May 31, 2036, covering 30,000 underlying common shares and vesting in one-third increments on the first three anniversaries of the grant date. In addition, he received 30,000 performance-based restricted shares, with the target number tied 50% to a Cumulative Same-Store Adjusted EBITDA Growth objective and 50% to a Cumulative Same-Store Net Revenue Growth objective over the 2026–2028 Performance Period. Between 0% and 200% of the target tied to each objective may ultimately vest on March 1, 2029, depending on actual performance.
Community Health Systems director K. R. Ranga reported compensation-related equity activity, primarily the settlement of deferred awards into common stock. On April 22, 2026, restricted stock units previously granted and deferred by the director converted into 46,950 shares of common stock through a derivative exercise.
Following this exercise, the director directly owned 156,093 shares of common stock, indicating the shares were retained rather than sold in the market. The director also continued to hold deferred equity, including restricted stock units totaling 228,321 units and stock units under a directors’ fee deferral plan representing 69,653.39 underlying common shares, which will settle later under pre-existing deferral elections.
Community Health Systems EVP Kevin A. Stockton reported multiple equity compensation moves in common stock and derivatives on March 1, 2026. He exercised 50,000 performance-based restricted shares and received new grants of 60,000 performance-based restricted shares and 30,000 stock options, all at a stated price of $0.00 per share. He also acquired 50,000 common shares through a derivative exercise and 30,000 additional restricted common shares, then had 35,573 common shares withheld at $3.46 per share to cover tax obligations. Following these transactions, he directly held 208,290 common shares. Footnotes explain that vesting of the performance-based awards depends on the company’s achievement of specified EBITDA and net revenue growth goals over performance periods running from 2024–2026, 2025–2027, and 2026–2028, with actual vesting ranging from 0% to 200% of target based on results.
Community Health Systems SVP & CAO Phillip A. Posey reported multiple equity awards in the latest insider filing. On March 1, 2026, he received grants of 25,000 performance-based restricted shares, 25,000 stock options, and 25,000 shares of common stock, all at a reported price of $0.00 per share, reflecting compensation awards rather than open-market purchases.
The performance-based restricted shares will vest based on Community Health Systems’ cumulative same-store adjusted EBITDA growth and cumulative same-store net revenue growth during the 2026–2028 performance period, with between 0% and 200% of the target vesting depending on results. The time-based restricted stock and stock options vest in one-third increments on the first, second, and third anniversaries of the grant date. The filing also shows a disposition of 1,188 shares of common stock at $3.46 per share to cover tax liabilities, leaving Posey with 51,736 common shares held directly after these transactions.
Community Health Systems executive Justin D. Pitt, President and Chief Legal & Administrative Officer, reported multiple equity transactions on 3/1/2026. He exercised 30,000 performance-based restricted shares, receiving 30,000 shares of common stock, and was granted 80,000 new performance-based restricted shares and 40,000 stock options. He also received a grant of 40,000 shares of restricted common stock. To cover tax obligations, 24,922 common shares were withheld at $3.46 per share. Following these transactions, Pitt directly held 287,750 shares of common stock. The new performance-based awards vest over multi‑year performance periods from 2024–2028 tied to revenue and Adjusted EBITDA growth, with potential vesting between 0% and 200% of target based on results.
Community Health Systems EVP & CFO Jason K. Johnson reported multiple equity transactions. On March 1, 2026, 30,000 performance-based restricted shares vested at 100% of target for the 2023–2025 performance period and were converted into 30,000 shares of common stock.
He was also granted 180,000 new performance-based restricted shares and 90,000 stock options, all held directly, with vesting tied to multi-year performance and time-based schedules described in the footnotes, including periods through 2028. In addition, he received 90,000 restricted shares of common stock, with restrictions lapsing in one-third increments over three years.
To cover tax obligations related to these awards, 23,610 shares of common stock were disposed of at $3.46 per share, leaving Johnson with 268,439 shares of common stock held directly after the transactions.
Community Health Systems CEO Kevin J. Hammons reported multiple equity compensation moves tied to performance and time-based awards. On March 1, 2026, he exercised 156,240 performance-based restricted shares into the same number of common shares and forfeited 23,760 performance-based restricted shares back to the issuer based on 2023–2025 performance, reflecting 86.8% achievement of the original target.
He received a new grant of 400,000 performance-based restricted shares tied to 2026–2028 performance objectives and 200,000 stock options (right to buy), as well as an award of 200,000 shares of common stock subject to time-vesting in one-third annual installments. To cover taxes, 96,896 common shares were disposed at $3.46 per share through share withholding, not an open-market sale. Following these transactions, he directly owned 895,545 shares of common stock, along with multiple outstanding performance-based restricted share and option positions.
Community Health Systems director Hubert James Williams reported multiple equity transactions in connection with his board service. On March 1, he received a grant of 52,023 restricted stock units (RSUs) at no cost. On the same date, several previously awarded RSUs were exercised and converted into common stock in amounts of 9,756, 20,906, and 19,933 shares on a one‑for‑one basis, consistent with the plan terms. Footnotes explain that some RSUs vest in thirds over three years and are settled in common stock either upon vesting or upon his cessation as a director or on dates he previously selected.
Community Health Systems Inc. director Wayne T. Smith reported routine equity activity. He received a grant of 52,023 restricted stock units, which will vest in three equal annual installments and be settled in common shares at specified future dates. He also made a bona fide gift of 19,400 common shares to individuals outside his household, leaving him with 5,217,579 common shares held directly after the gift.
LOPEZ FAWN D reported acquisition or exercise transactions in this Form 4 filing.
COMMUNITY HEALTH SYSTEMS INC director Fawn D. Lopez received a grant of 52,023 restricted stock units on March 1, 2026. The award was granted at no cash cost and increased her directly held restricted stock units to 122,519 in total.
These restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the grant date. Upon vesting, they are scheduled to be settled in shares of common stock on a one-for-one basis, subject to prior deferral elections that can delay settlement until she ceases to be a director or until specified future dates.
Krishnan K Ranga reported acquisition or exercise transactions in this Form 4 filing.
Community Health Systems director K Ranga Krishnan received a grant of 52,023 restricted stock units on March 1, 2026. The award increases his directly held restricted stock units to 275,271. These units vest in three equal annual installments and will be settled in common shares, generally after his service as a director ends.
JENNINGS WILLIAM NORRIS reported acquisition or exercise transactions in this Form 4 filing.
COMMUNITY HEALTH SYSTEMS INC director William Norris Jennings reported an award of restricted stock units. He received 52,023 Restricted Stock Units on March 1, 2026 as a grant at no cash cost. These units vest in three equal installments on the first, second, and third anniversaries of the grant date.
According to his prior deferral elections, the units will be settled in an equal number of Community Health Systems common shares when he ceases to be a director or on previously specified dates. After this award, he directly holds 275,271 restricted stock units and 78,468 shares of common stock.
Community Health Systems Inc. director Elizabeth T. Hirsch reported multiple equity transactions on March 1, 2026. She exercised or converted restricted stock units into common stock in three blocks of 9,756, 20,906 and 19,933 shares at $0.00 per share, increasing her direct common share holdings.
Hirsch was also granted or awarded 52,023 restricted stock units, which vest in one-third increments on the first, second and third anniversaries of the grant date. According to the filing, restricted stock units convert to common stock on a one-to-one basis, and 34,483 restricted stock units are shown as held directly after these transactions.
Hastings Joseph Arthur reported acquisition or exercise transactions in this Form 4 filing.
Community Health Systems director Joseph Arthur Hastings received a grant of 52,023 restricted stock units on Community Health Systems common stock. These units increase his directly held RSU balance to 221,492 units.
The RSUs vest in equal one-third installments on the first, second and third anniversaries of the grant date. According to the award terms, they will be settled in shares of common stock on a one-for-one basis upon his cessation as a director or on dates he previously specified. As of the reported date, he also held 10,792 shares of common stock directly and 6,338 shares indirectly through the Joanne L. Hastings Irrevocable Trust, where he serves as trustee.
Community Health Systems Inc. director John A. Fry reported multiple equity-related transactions involving restricted stock units (RSUs) and common stock. On March 1 2026, he exercised RSUs that convert to common stock on a one-to-one basis, acquiring 9756, 20906, and 19933 shares of common stock at a stated price of 0.0000 per share. The filing also shows a new grant of 52023 RSUs that vest in one-third increments on the first, second, and third anniversaries of the grant date and will be settled in common stock upon vesting. After these conversions, Fry directly owned 268966 shares of Community Health Systems common stock.
COMMUNITY HEALTH SYSTEMS INC director James S. Ely III reported multiple equity transactions involving restricted stock units and common shares of CYH.
On March 1, 2026, he exercised several blocks of restricted stock units, receiving matching amounts of common stock at a price of $0.00 per share, which increased his direct common stock holdings to 412,876 shares. He also received a new grant of 52,023 restricted stock units that will settle in common stock under the company’s award terms.
Following these transactions, he directly holds 53,779 restricted stock units and 13,085.472 stock units under a directors’ fee deferral plan, each convertible into common stock on a one-for-one basis under specified conditions. In addition, 4,990 common shares are held indirectly through E5 Investors LLC.
COMMUNITY HEALTH SYSTEMS INC director Michael Dinkins reported equity awards and conversions involving restricted stock units and common shares. On 2026-03-01, he exercised or converted restricted stock units into 9,756 and 20,906 shares of common stock at a stated price of $0.0000 per share, increasing his direct common stock holdings to 225,882 shares.
He also acquired a new grant of 52,023 restricted stock units, bringing his directly held restricted stock units to 111,824. The units generally convert to common stock on a one-to-one basis and vest in one-third increments on the first, second, and third anniversaries of the grant date, with some units deferred until he ceases serving as a director or specified future dates.
Community Health Systems director John A. Clerico reported multiple equity transactions dated March 1, 2026. He exercised previously granted restricted stock units that converted one-for-one into 50,595 shares of common stock at a stated price of $0.00 per share.
Clerico also received a new award of 52,023 restricted stock units that vest in equal one-third installments on the first, second and third anniversaries of the grant date and are settled in common shares on a one-for-one basis. Following these transactions, he directly holds 368,763 shares of common stock and 52,023 restricted stock units.
BURGESS RONALD L JR reported acquisition or exercise transactions in this Form 4 filing.
COMMUNITY HEALTH SYSTEMS INC director Ronald L. Burgess Jr. received a grant of 52,023 restricted stock units on March 1, 2026. These units vest in one-third increments on the first, second and third anniversaries of the grant date.
According to his prior deferral elections, the restricted stock units will be settled in an equal number of shares of common stock upon his cessation as a director or on specified future dates. After this grant, he directly held 174,542 restricted stock units and no shares of common stock.
Community Health Systems director Susan W. Brooks reported multiple equity transactions on March 1, 2026. She exercised restricted stock units that convert to common stock on a one-to-one basis, acquiring 50,595 shares of common stock. She also received a new grant of 52,023 restricted stock units, which vest in one-third increments on the first, second and third anniversaries of the grant date and will be settled in common stock on a one-for-one basis. Following these transactions, she directly owned 108,695 shares of common stock and 52,023 restricted stock units.
Community Health Systems director equity activity: On 12/31/2025, a director of Community Health Systems, Inc. converted 2,882 stock units into shares of common stock at an exercise price of $0 under the company’s Directors' Fees Deferral Plan. After this transaction, the director beneficially owned 362,281 shares of common stock directly and 4,990 shares indirectly through E5 Investors LLC.
The filing also shows ongoing deferred compensation and equity awards. The director holds 13,085.472 stock units and several blocks of restricted stock units, including 53,779, 9,756, 41,812, and 59,801 units. These units generally vest in one‑third increments on the first, second, and third anniversaries of the grant date and will be settled on a one‑for‑one basis in shares of common stock, either upon or following the director’s cessation of service, depending on prior deferral elections.